Wall Street edged higher ahead of Fed's interest rate verdict
Wall Street's main indexes ticked up on Wednesday, as investors awaited the Federal Reserve's monetary policy decision, while the Israel-Iran attacks entered the sixth day.
Investors will closely monitor Fed Chair Jerome Powell's comments to gauge how he plans to combat the risk of rising prices, which remains a dominant concern for the central bank. The Fed is expected to leave rates unchanged at its meeting, scheduled later in the day.
'We're still at the beginning stages of feeling that real income shock from higher tariffs in the United States, and the uncertainty effect builds up over time,' said Simon Dangoor, head of fixed income macro strategies at Goldman Sachs Asset Management.
'So I think the next couple of months of data is going to be really key about where we go from here.'
Ahead of the monetary policy decision, money market moves show traders are pricing in about 46 basis points of rate cuts by the end of 2025, with a 55% chance of a 25-bps rate cut in September, according to CME Group's FedWatch tool.
Wall St climbs as oil prices ease, Fed meeting in focus
Following strong monthly equity trading in May, the benchmark S&P 500 index and the Nasdaq were close to record peaks before the ongoing conflict in the Middle East made investors risk averse.
The S&P 500 index stood 2.5% below its record level, and the tech-heavy Nasdaq remained 3.3% lower.
Investors have been anxious over the possibility of a more direct U.S. military involvement in the Israel-Iran aerial war.
A source familiar with internal discussions said U.S. President Donald Trump and his team were considering a number of options, which included joining Israel in strikes against Iranian nuclear sites.
At 09:52 a.m. ET, the Dow Jones Industrial Average rose 73.93 points, or 0.18%, to 42,289.73, the S&P 500 gained 13.90 points, or 0.23%, to 5,996.62 and the Nasdaq Composite gained 49.31 points, or 0.26%, to 19,571.01.
Ten of the 11 major S&P 500 sub-sectors rose. Energy and consumer discretionary stocks gained 0.6% each, while healthcare stocks declined 0.4%.
Tesla gained 1.8%.
Shares of networking and custom AI chipmaker Marvell Technology hit a three-month high and were last up 8.7%.
Shares of stablecoin issuer Circle Internet rose 6.2% after the U.S. Senate passed a bill to create a regulatory framework for dollar-pegged cryptocurrency tokens known as stablecoins.
Scholar Rock rose 17.4% after the drugmaker said its experimental drug helped overweight patients preserve lean mass in a mid-stage trial when used in combination with Eli Lilly's weight-loss treatment.
Steelmaker Nucor rose 4.9% following a second-quarter profit forecast that came above analysts' estimates.
Initial jobless claims data on Wednesday showed the number of Americans filing new applications for unemployment benefits fell last week, but stayed at levels consistent with a further loss of labor market momentum in June.
Advancing issues outnumbered decliners by a 1.63-to-1 ratio on the NYSE and by a 1.3-to-1 ratio on the Nasdaq.
The S&P 500 posted four new 52-week highs and six new lows, while the Nasdaq Composite recorded 31 new highs and 53 new lows.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
an hour ago
- Business Recorder
UK stocks end slightly higher after inflation data; focus on Fed, BoE meetings
Britain's FTSE 100 rose on Wednesday as investors weighed the last domestic inflation reading ahead of key central bank meetings in the U.S. and the UK, though Middle East tensions tempered market optimism. The blue-chip FTSE 100 index ended 0.1% higher, as heavyweight banks recouped lost ground to rise 1.1%. British inflation slowed in May, as expected by the Bank of England, which is widely predicted to keep interest rates on hold when it meets on Thursday. 'Escalating tensions in the Middle East, and the upward pressure this is putting on oil prices, will only add to the Bank of England's concern about easing rates too quickly,' said Zara Nokes, global market analyst at J.P. Morgan Asset Management. 'The Monetary Policy Committee will face a tougher choice when meeting again in August, given the combination of still-sticky inflation and evidence that the labour market is quite clearly cooling.' The conflict between Iran and Israel entered its sixth day, with increasing concerns over direct U.S. military involvement after Iranian Supreme Leader Ayatollah Ali Khamenei rejected U.S. President Donald Trump's demand for unconditional surrender. UK stocks fall as Middle East conflict hits risk appetite Pharmaceutical and biotechnology stocks were under pressure, with GSK and AstraZeneca both down 2.1% and 1.1%, respectively, after Trump said pharma tariffs were coming soon. The midcap index climbed 0.3%, with shares of ME Group jumping 9% after the vending machines operator confirmed it is evaluating strategic options, including a sale. Electronics retailer AO World posted record profits in fiscal 2025. Its shares, however, closed 3.6% lower after an initial spike. Across the Atlantic, the Federal Reserve's policy decision later in the day will be under scrutiny as investors try to gauge expectations for rate cuts. Other economic data showed that UK house price growth halved in April.
Express Tribune
an hour ago
- Express Tribune
Erdogan backs Iran's right to self-defence, slams Israel's ‘thuggery'
Listen to article Turkish President Recep Tayyip Erdogan said Wednesday Iran had the "legitimate" right to defend itself in the face of Israel's ongoing bombing campaign, now in its sixth day. "It is a very natural, legitimate and legal right for Iran to defend itself against Israel's thuggery and state terrorism," the Turkish leader said, a day after referring to Israeli Prime Minister Benjamin Netanyahu as "the biggest threat to the security of the region". The long-range blitz began early Friday, when Israel launched a massive bombing campaign that prompted Iran to hit back with missiles and drones, including hypersonic missiles. "These attacks were organised while the Iranian nuclear negotiations were taking place," Erdogan said. Read More: Trump says Iranians reached out but it's 'very late to be talking' "Israel, which possesses nuclear weapons and does not recognise any international rules... did not wait for the negotiations to end but carried out a terrorist act without waiting for the result," he added. Iran says at least 224 people have been killed in the Israeli attacks, which have targeted nuclear and military facilities, while Iranian fire on Israel has claimed at least 24 lives and wounded hundreds more, Netanyahu's office said. "We are closely following Israel's terrorist attacks on Iran. All our institutions are on high alert regarding the possible effects of these attacks on Turkiye," Erdogan said. "We are making preparations for every kind of scenario," he said. "Nobody should dare to test us. We don't have any desire to take other people's lands... in the region," he added. His remarks prompted a sharp riposte from Israeli Foreign Minister Gideon Saar, who pointed to Turkiye's presence in Syria and in the divided island of Cyprus, where it controls the northern part. Kendini bir sultan gibi gören Erdoğan, bir başka coşkulu ve saldırgan konuşmasında, İsrail ve İsrail Başbakanı aleyhindeki kışkırtıcı söylemlerini sürdürmeye devam ediyor. Vatandaşlarının özgürlüklerini ve haklarını bastırmakta, aynı şekilde ülkesindeki muhalefeti sindirmekte… — Gideon Sa'ar | גדעון סער (@gidonsaar) June 18, 2025 "It is particularly ironic that someone who does not hide his imperialist ambitions, who invaded northern Syria and illegally holds northern Cyprus, claims to speak in the name of morality and international law," Saar wrote on X. "A little self-awareness could be helpful," he added. On Monday, Erdogan said he had ordered the defence industry to increase production of medium and long-range missiles to "increase its level of deterrence" in light of the air war between Israel and Iran.
Business Recorder
an hour ago
- Business Recorder
European shares fall as Middle East tensions weigh; eyes on Fed decision
European shares declined on Wednesday as investors awaited the Federal Reserve's monetary policy decision, with ongoing tensions in the Middle East adding to market uncertainty. The pan-European STOXX 600 index closed 0.4% down, at a near one-month low. The hostilities between Iran and Israel extended to a sixth day, with fears of a more direct U.S. involvement after President Donald Trump asked for Iran's 'unconditional surrender'. However, Iranian Supreme Leader Ayatollah Ali Khamenei rejected Trump's demand for surrender. Defence stocks were among the biggest gainers, with the sector up 0.6%. Traders also stayed away from risk assets ahead of the Federal Reserve's policy meeting at 1800 GMT, where officials are widely expected to hold interest rates steady. Investors will closely watch policymakers' comments for signals on how the U.S. central bank plans to navigate an uncertain trade environment. 'Rising geopolitical and trade uncertainties mean the Fed's growth and inflation forecasts may lack precision.', said Ipek Ozkardeskaya, senior analyst at Swissquote Bank. European shares slide as Israel-Iran conflict shows no sign of cooling The Fed faces additional challenges from potential inflation risks stemming from the escalating Middle East crisis. As the July 8 tariff-pause deadline approaches, many countries, including the EU are scrambling to strike a deal with Washington. European Commission President Ursula von der Leyen was still aiming to reach a deal by July 9. The only formal deal signed was the finalization of the U.S.-UK agreement announced last month. Other major bourses indexes were largely mixed. London's FTSE 100 closed up 0.1% after data showed that British inflation eased as expected in May. Investors are now eyeing the Bank of England's rate decision on Thursday. 'With services inflation still elevated… the BoE looks nailed on to keep rates unchanged,' said Ruth Gregory, deputy chief UK economist at Capital Economics. Sweden's central bank cut its key interest rate to 2.00% from 2.25% as expected. Still, Stockholm's benchmark index dropped 0.1%. The healthcare sector was the biggest drag on the benchmark index, weighed down by a 1% drop by heavyweight Novo Nordisk. A U.S. judge upheld the U.S. Food and Drug Administration's decision to remove the pharma giant's blockbuster drugs Ozempic and Wegovy from the drug shortage list. Barclays forecasts a year-end 2026 target of 620 for the STOXX 600, citing Germany's stimulus measures and rate cuts as key drivers for this optimistic outlook. French outsourcing firm TP dropped 13.6% to the bottom of STOXX 600 after announcing new medium-term targets. Gerresheimer rose 6.3% after the German medical packaging maker said it was informed KPS Capital Partners was still in talks with Warburg Pincus on a potential joint takeover bid.
